{"id":19443,"date":"2021-11-12T10:48:24","date_gmt":"2021-11-12T09:48:24","guid":{"rendered":"https:\/\/idibell.cat\/?p=19443"},"modified":"2021-11-12T10:48:24","modified_gmt":"2021-11-12T09:48:24","slug":"la-unitat-dinnovacio-i-desenvolupament-de-negoci-de-lidibell-participa-en-el-congres-dindustries-biotecnologiques-mes-important-deuropa","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2021\/11\/la-unitat-dinnovacio-i-desenvolupament-de-negoci-de-lidibell-participa-en-el-congres-dindustries-biotecnologiques-mes-important-deuropa\/","title":{"rendered":"La Unitat d&#8217;Innovaci\u00f3 i Desenvolupament de Negoci de l&#8217;IDIBELL participa en el congr\u00e9s d&#8217;ind\u00fastries biotecnol\u00f2giques m\u00e9s important d&#8217;Europa"},"content":{"rendered":"<p>L&#8217;\u00c0rea d&#8217;Innovaci\u00f3 i Desenvolupament de Negoci de l&#8217;IDIBELL ha assistit a la trobada <strong>BIO-Europe Digital 2021<\/strong>. Aquest \u00e9s l&#8217;esdeveniment m\u00e9s important de la ind\u00fastria biotecnol\u00f2gica, farmac\u00e8utica i financera especialitzada en les ci\u00e8ncies de la vida en l&#8217;\u00e0mbit europeu. El BIO-Europe atrau un ampli ventall de l\u00edders empresarials, incloent-hi executius l\u00edders de companyies biotecnol\u00f2giques, equips de desenvolupament de negoci, inversors i altres experts de la ind\u00fastria.<\/p>\n<p>Durant el congr\u00e9s, que va tenir lloc del 25 al 28 d&#8217;octubre, els representants de l&#8217;IDIBELL van assistir a un total de <strong>63 reunions amb 43 farmac\u00e8utiques, 8 companyies de capital risc, 6 delegats i 6 experts cient\u00edfics<\/strong>. &#8220;<em>Esperem aprofitar l&#8217;impuls que acabem de crear durant BIO-Europa per seguir col\u00b7laborant i creixent durant el 2022<\/em>&#8220;, conclouen des de l&#8217;\u00c0rea d&#8217;Innovaci\u00f3 i desenvolupament de negoci.<\/p>\n<p>Generar acords i connectar amb companys i companyes del sector segueix sent una part rellevant de la creaci\u00f3 de projectes d&#8217;\u00e8xit. Segons els organitzadors, aquesta edici\u00f3 del BIO-Europe van ser 4 dies intensos amb la participaci\u00f3 de 2.941 delegats de 1.686 empreses representants de 55 pa\u00efsos que van participar a m\u00e9s de 15.000 reunions.<\/p>\n<p>El 2022 BIO-Europe ser\u00e0 en format presencial i tindr\u00e0 lloc Leipzig, Alemanya, en els propers 24-26 d&#8217;octubre. Aquesta ser\u00e0 la primera sessi\u00f3 presencial des del 2019.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em>L\u2019Institut d&#8217;Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l&#8217;Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l&#8217;Institut Catal\u00e0 de la Salut, l&#8217;Institut Catal\u00e0 d&#8217;Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n<p><em>L\u2019IDIBELL \u00e9s membre del Campus d&#8217;Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L&#8217;any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aquest \u00e9s l&#8217;esdeveniment m\u00e9s important de la ind\u00fastria biotecnol\u00f2gica, farmac\u00e8utica i financera especialitzada en les ci\u00e8ncies de la vida en l&#8217;\u00e0mbit europeu<\/p>\n","protected":false},"author":8,"featured_media":19444,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[493],"tags":[],"publishpress_future_action":{"enabled":false,"date":"2024-05-08 20:40:31","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/19443"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=19443"}],"version-history":[{"count":2,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/19443\/revisions"}],"predecessor-version":[{"id":19446,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/19443\/revisions\/19446"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/19444"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=19443"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=19443"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=19443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}